Extremities Regulatory Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin byTim AllenDecember 15, 2025
Financial Hospitals Regulatory Top Stories Bioretec’s RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US byNoah SimmonsOctober 1, 2025
Extremities Regulatory Top Stories CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec byBree MillerFebruary 14, 2025
Extremities Regulatory Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe byTim AllenJanuary 31, 2025
Extremities The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement byJosh SandbergNovember 20, 2024
Spine Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage byJosh SandbergOctober 4, 2024
Financial Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results byJosh SandbergAugust 15, 2024
Extremities Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures byTim AllenJune 19, 2024
Regulatory Spine Top Stories Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage byJosh SandbergMarch 14, 2024
Extremities Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws byJosh SandbergSeptember 12, 2023
